Pipeline: Gryphon Bio is developing its own promising, diversified pipeline of lead therapeutic bioconjugates to accelerate brain repair and improve cognition by following clues from nature’s sequence of cellular and molecular events for rush delivery of medicines to the brain. Each compound has a unique mechanism(s) of action (MOA) and pharmacokinetic/pharmacodynamic (PK/PD) profile, compelling biology, and binds to a novel or de-risked therapeutic target.